IPO stocks are expected to see a bright year ahead this 2025, especially backed by the ongoing bull run at the US stock ...

(Bloomberg) -- European stocks closed at a record high, as corporate earnings kicked into high gear.

Temasek Holdings and TPG-backed Dr Agarwal's Health Care, an eye care services provider, on Friday, said it has fixed a price ...

EQT, one of Europe's largest buyout firms, is hopeful that there will be more dealmaking and other opportunities to return cash to investors in 2025 as conditions in the public and private markets ...

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...

Thus far in the month of January 2025, the BSE IPO index has tanked 11 per cent, as against 2.6 per cent decline in the BSE ...

Even as FIIs consider valuations in the secondary market high, they remain upbeat on India's market narrative, compelling them to seize every opportunity, say experts.

Dr Agarwal's Healthcare IPO price band is set at ₹382 to ₹402 per equity share. The subscription date is from January 29 to January 31.

EMA Partners shares will list on the NSE SME platform with an expected 28% listing gain over the issue price. The IPO, ...

Liquefied natural gas exporter Venture Global said on Thursday it had raised $1.75 billion, marking the first big initial ...

Ascentage Pharma said on Thursday it aims to raise $126.4 million in an initial public offering in the United States, becoming the first sizeable Chinese firm to seek a listing in the U.S. this year.

Venture Global is the second-largest exporter of liquefied natural gas, or LNG, in the United States, and one of Trump's ...